PRO DEX INC (PDEX)
About PRO DEX INC
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $66.6M
- Net income
- $9.0M
- Total assets
- $61.2M
- Market cap
- $208.2M
- Gross margin
- 29.3%
- Operating margin
- 16.1%
- Net margin
- 0.2%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $66.6M
- Cost of revenue
- $47.1M
- Gross profit
- $19.5M
- Operating expenses
- $8.8M
- Operating income
- $10.7M
- Income tax
- $3.1M
- Net income
- $155.0K
- EPS (basic)
- $2.73
- EPS (diluted)
- $2.67
Balance sheet
- Total assets
- $61.2M
- Current assets
- $47.3M
- Total liabilities
- $24.6M
- Current liabilities
- $14.6M
- Shareholders’ equity
- $36.6M
Cash flow
- Operating cash flow
- -$1.7M
- Investing cash flow
- -$238.0K
- Financing cash flow
- -$292.0K
- Net cash flow
- -$2.2M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $208.2M
- P/E ratio
- 20.6
- EPS (diluted)
- $2.67
- Shares outstanding
- 3.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 7, 1986
PRO DEX Inc (PDEX) Stock Price
- Profitable — net income of $9.0M in FY2025.
- Revenue grew 75% from FY2021 to FY2025.
- Gross margin of 29.3%, net margin 0.2%.
- Trading 19% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 20.6.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PRO DEX INC.
Write a review
News about PRO DEX INC
News & sentiment via Polygon.io
PRO DEX Inc: frequently asked questions
Is PRO DEX Inc an American company?
PRO DEX Inc is a US-based company headquartered in Irvine, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is PRO DEX Inc headquartered?
PRO DEX Inc is headquartered in Irvine, California, United States.
Is PRO DEX Inc publicly traded?
Yes — PRO DEX Inc is a publicly traded company. Its stock trades under the ticker symbol PDEX on the NASDAQ.
What does PRO DEX Inc do?
PRO DEX Inc is an American Medical Devices company in the Health & Beauty sector.
